Daxiang Biotech | Leading Organoids-on-Chips Innovator

Select the model you are interested in

PRODUCT

SERVICE

01Organoids-On-Chips

We provide Organoids-On-Chips of various specifications for you to carry out in vitro model construction and related research

Organoids-On-Chips

02In vitro model

We provide a variety of single-organ, multi-organ and barrier models in vitro to meet your research needs

In vitro model

03Technical service

We provide pharmacological, toxicological and basic scientific research services based on a variety of innovative in vitro models

Technical service

CORE TECHNOLOGY

Organoids-on-Chips

IBAC®

The next-generation high-throughput, high-bionic in vitro model construction platform created by combining the two cutting-edge technologies of organoid and organ chip has a wide range of applications in new drug research and development, disease modeling and personalized precision medicine.

Daxiang Biotech Joins Scientist.com, Expanding Global Access to Its Organoid-on-Chip Services

Daxiang Biotech has joined Scientist.com as a Registered Supplier, creating a new way for pharmaceutical, biotech, and research organizations worldwide to access its organoid, organoid-on-chip, and microphysiological system (MPS) technologies and research services.

Daxiang Biotech Wins Second Prize at the HICOOL 2026 Global Entrepreneur Summit

Daxiang Biotech has been awarded Second Prize in the Finals of the HICOOL 2026 Global Entrepreneurship Competition, recognizing the company's innovation and commercialization efforts in organoid-on-chip technology.

Advancing Human-Relevant Tumor Models at the 14th Tumor Models Summit Boston

Daxiang Biotech joined the 14th Tumor Models Summit Boston, held July 29–30, 2026, alongside researchers and industry leaders working to advance more predictive and translationally relevant models for oncology drug development.

China's Organoids-on-Chips Leader